Create Account | Sign In: Author or Forum

 
 
News  |  Journals  |  Conferences  |  Blogs  |  Articles  |  Forums  |  Twitter    
 

 Headlines:

 

Category: Family Medicine | Oncology | Pediatrics | Journal

Back to Journal Articles

Kids’ Cancer Survival Low in Many Countries

Last Updated: July 29, 2008.

 

Survey finds 'dismal' chances in less developed countries; survival linked to health expenditures

Share |

Comments: (0)

Tell-a-Friend

 

  Related
 
Annual per-capita government health expenditures are associated with survival of children with cancer in 10 low- and middle-income countries, and half of these countries offer very poor chances of survival for these children, according to research published in the August issue of The Lancet Oncology.

TUESDAY, July 29 (HealthDay News) -- Annual per-capita government health expenditures are associated with survival of children with cancer in 10 low- and middle-income countries, and half of these countries offer very poor chances of survival for these children, according to research published in the August issue of The Lancet Oncology.

Raul C. Ribeiro, M.D., of St. Jude Children's Research Hospital in Memphis, Tenn., and colleagues assessed interviews with health-related professionals and analyzed other data from 10 countries receiving support from the My Child Matters pediatric cancer funding program.

Postulated five-year survival was 5 percent to 10 percent in Bangladesh, the Philippines, Senegal, Tanzania and Vietnam; 30 percent in Morocco; and between 40 percent and 60 percent in Egypt, Honduras, Ukraine and Venezuela. Postulated survival was correlated with annual government health expenditure per capita in the countries overall, per capita gross domestic product and number of physicians and nurses per 1,000 people.

"Detailed surveys can provide useful data for baseline assessment of the status of paediatric oncology, but cannot substitute for national cancer registration. Alliances between public, private, and international agencies might rapidly improve the outcome of children with cancer in these countries," Ribeiro writes.

Two co-authors are employees of Sanofi-Aventis, which partly funded the study and is a backer of the My Child Matters program.

Abstract
Full Text (subscription or payment may be required)

Copyright © 2008 ScoutNews, LLC. All rights reserved.


Previous: Tocolytics Commonly Prescribed for Preterm Labor Next: July 2008 Briefing - Family Practice

Reader comments on this article are listed below. Review our comments policy.


Submit your opinion:

Name:

Email:

Location:

URL:

Remember my personal information

Notify me of follow-up comments?

advertisement.gif (61x7 -- 0 bytes)
 

Are you a Doctor, Pharmacist, PA or a Nurse?

Join the Doctors Lounge online medical community

  • Editorial activities: Publish, peer review, edit online articles.

  • Ask a Doctor Teams: Respond to patient questions and discuss challenging presentations with other members.

Doctors Lounge Membership Application

 
     

 advertisement.gif (61x7 -- 0 bytes)

 

 

Useful Sites
MediLexicon
  Tools & Services: Follow DoctorsLounge on Twitter Follow us on Twitter | RSS News | Newsletter | Contact us
Copyright © 2001-2014
Doctors Lounge.
All rights reserved.

Medical Reference:
Diseases | Symptoms
Drugs | Labs | Procedures
Software | Tutorials

Advertising
Links | Humor
Forum Archive
CME | Conferences

Privacy Statement
Terms & Conditions
Editorial Board
About us | Email

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.